For example, in cervical cancer, the downregulation of KIF2C can promote the activation of the p53 signal pathway [42]; in hepatocellular carcinoma, KIF2C promotes the development of hepatocellular carcinoma through the Ras/MAPK and PI3K/Akt signal pathways [43]. This evidence concerns the gene KIF2C and hepatocellular carcinoma.